Arkolith/Insider Trading/AAPG/Form 4

Zhai Yifan

Chief Medical OfficerASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) · full profile →Form 4 · filed May 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
2 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2026Option exercise(M)96K—$01.2M
May 21, 2026Option exercise(M)93K—$0405K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 21, 2026Option exercise(M)96K—$00
May 21, 2026Option exercise(M)93K—$00
May 20, 2026Grant(A)103K—$0103K
May 20, 2026Grant(A)93K—$093K
May 20, 2026Grant(A)96K—$096K
May 20, 2026Grant(A)298K—$0298K
May 20, 2026Grant(A)298K—$0298K
May 20, 2026Grant(A)103K—$0103K
May 20, 2026Grant(A)215K—$0215K
May 20, 2026Grant(A)215K—$0215K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-060632) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML